Avalo Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Avalo Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2014 to Q3 2024.
  • Avalo Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 9.68M shares, a 95% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 9.68M -183M -95% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 1.03M -13M -92.6% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 1.03M -12.2M -92.2% Mar 31, 2024 10-Q/A 2024-07-11
Q4 2023 802K +762K Dec 31, 2023 10-Q 2024-11-07
Q3 2023 192M +183M +1944% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 14M +4.63M +49.2% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 13.2M -99.6M -88.3% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 39.3K* -9.36M Dec 31, 2022 10-K 2024-03-29
Q3 2022 9.41M -103M -91.6% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 9.41M -86.6M -90.2% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 113M +23.7M +26.6% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 9.4M -65.6M -87.5% Dec 31, 2021 10-K 2023-03-29
Q3 2021 112M +37.4M +50% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 96M +21.1M +28.2% Jun 30, 2021 10-Q 2021-08-02
Q1 2021 89.1M +29.5M +49.6% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 75M +30.6M +69% Dec 31, 2020 10-K 2022-03-02
Q3 2020 74.9M +30.8M +69.8% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 74.9M +32M +74.6% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 59.6M +16.8M +39.3% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 44.4M +3.58M +8.77% Dec 31, 2019 10-K 2021-03-08
Q3 2019 44.1M +3.43M +8.43% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 42.9M +9.11M +27% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 42.8M +11.3M +36.1% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 40.8M +9.54M +30.5% Dec 31, 2018 10-K 2020-03-11
Q3 2018 40.7M +14.6M +56.1% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 33.8M +19.7M +139% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 31.4M +20.5M +188% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 31.3M +21.8M +231% Dec 31, 2017 10-K 2019-03-18
Q3 2017 26.1M +17M +187% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 14.1M +5.46M +63.2% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 10.9M +2.25M +26% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 9.43M +784K +9.06% Dec 31, 2016 10-K 2018-04-02
Q3 2016 9.08M +8.43M +1297% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 8.65M Jun 30, 2016 10-Q 2016-08-15
Q1 2016 8.65M Mar 31, 2016 10-Q 2016-05-16
Q4 2015 8.65M +8M +1231% Dec 31, 2015 10-K 2017-03-14
Q3 2015 650K Sep 30, 2015 10-Q 2015-11-13
Q4 2014 650K Dec 31, 2014 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.